Global Short Bowel Syndrome (SBS) Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Page: 94
Published Date: 04 Jan 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.
According to our (Global Info Research) latest study, the global Short Bowel Syndrome (SBS) Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
During 2017, the parental route segment accounted for the major shares and dominated the SBS market. Factors such as the rapid action mechanism of the drug and the prolonged action result contribute to the growth of this market segment in the coming years. In the parental route, the drug is administered intravenously, subcutaneously, intrathecally, or through intramuscular routes and is applied when the oral route of drug administration is ineffective.
This report is a detailed and comprehensive analysis for global Short Bowel Syndrome (SBS) Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Sale Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Short Bowel Syndrome (SBS) Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Short Bowel Syndrome (SBS) Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Short Bowel Syndrome (SBS) Drugs market size and forecasts, by Type and by Sale Channel, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Short Bowel Syndrome (SBS) Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Short Bowel Syndrome (SBS) Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Short Bowel Syndrome (SBS) Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Takeda, Emmaus Medical, Ardelyx and Naia Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Short Bowel Syndrome (SBS) Drugs market is split by Type and by Sale Channel. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sale Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Glucagon-Like Peptide-2 (GLP-2)
Growth Hormone
Glutamine
Other
Market segment by Sale Channel
Hospitals
Clinics
Retail Pharmacies
Major players covered
Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Short Bowel Syndrome (SBS) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Short Bowel Syndrome (SBS) Drugs, with price, sales, revenue and global market share of Short Bowel Syndrome (SBS) Drugs from 2018 to 2023.
Chapter 3, the Short Bowel Syndrome (SBS) Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Short Bowel Syndrome (SBS) Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and sale channel, with sales market share and growth rate by type, sale channel, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Short Bowel Syndrome (SBS) Drugs market forecast, by regions, type and sale channel, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Short Bowel Syndrome (SBS) Drugs.
Chapter 14 and 15, to describe Short Bowel Syndrome (SBS) Drugs sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Short Bowel Syndrome (SBS) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Glucagon-Like Peptide-2 (GLP-2)
1.3.3 Growth Hormone
1.3.4 Glutamine
1.3.5 Other
1.4 Market Analysis by Sale Channel
1.4.1 Overview: Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Sale Channel: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Retail Pharmacies
1.5 Global Short Bowel Syndrome (SBS) Drugs Market Size & Forecast
1.5.1 Global Short Bowel Syndrome (SBS) Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Short Bowel Syndrome (SBS) Drugs Sales Quantity (2018-2029)
1.5.3 Global Short Bowel Syndrome (SBS) Drugs Average Price (2018-2029)
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Short Bowel Syndrome (SBS) Drugs Product and Services
2.1.4 Merck Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Short Bowel Syndrome (SBS) Drugs Product and Services
2.2.4 Takeda Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Takeda Recent Developments/Updates
2.3 Emmaus Medical
2.3.1 Emmaus Medical Details
2.3.2 Emmaus Medical Major Business
2.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product and Services
2.3.4 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Emmaus Medical Recent Developments/Updates
2.4 Ardelyx
2.4.1 Ardelyx Details
2.4.2 Ardelyx Major Business
2.4.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Product and Services
2.4.4 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ardelyx Recent Developments/Updates
2.5 Naia Pharmaceuticals
2.5.1 Naia Pharmaceuticals Details
2.5.2 Naia Pharmaceuticals Major Business
2.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Services
2.5.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Naia Pharmaceuticals Recent Developments/Updates
2.6 Nutrinia
2.6.1 Nutrinia Details
2.6.2 Nutrinia Major Business
2.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Product and Services
2.6.4 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Nutrinia Recent Developments/Updates
2.7 OxThera
2.7.1 OxThera Details
2.7.2 OxThera Major Business
2.7.3 OxThera Short Bowel Syndrome (SBS) Drugs Product and Services
2.7.4 OxThera Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 OxThera Recent Developments/Updates
2.8 Sancilio Pharmaceuticals
2.8.1 Sancilio Pharmaceuticals Details
2.8.2 Sancilio Pharmaceuticals Major Business
2.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Services
2.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sancilio Pharmaceuticals Recent Developments/Updates
2.9 Zealand Pharma
2.9.1 Zealand Pharma Details
2.9.2 Zealand Pharma Major Business
2.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product and Services
2.9.4 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Zealand Pharma Recent Developments/Updates
3.1 Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Short Bowel Syndrome (SBS) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Short Bowel Syndrome (SBS) Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Short Bowel Syndrome (SBS) Drugs Manufacturer Market Share in 2022
3.5 Short Bowel Syndrome (SBS) Drugs Market: Overall Company Footprint Analysis
3.5.1 Short Bowel Syndrome (SBS) Drugs Market: Region Footprint
3.5.2 Short Bowel Syndrome (SBS) Drugs Market: Company Product Type Footprint
3.5.3 Short Bowel Syndrome (SBS) Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Short Bowel Syndrome (SBS) Drugs Market Size by Region
4.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Region (2018-2029)
4.2 North America Short Bowel Syndrome (SBS) Drugs Consumption Value (2018-2029)
4.3 Europe Short Bowel Syndrome (SBS) Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Consumption Value (2018-2029)
4.5 South America Short Bowel Syndrome (SBS) Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Consumption Value (2018-2029)
5.1 Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2018-2029)
5.2 Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Type (2018-2029)
5.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Type (2018-2029)
6.1 Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2018-2029)
6.2 Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Sale Channel (2018-2029)
6.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Sale Channel (2018-2029)
7.1 North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2018-2029)
7.2 North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2018-2029)
7.3 North America Short Bowel Syndrome (SBS) Drugs Market Size by Country
7.3.1 North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8.1 Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2018-2029)
8.3 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Country
8.3.1 Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2018-2029)
9.3 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Size by Region
9.3.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10.1 South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2018-2029)
10.2 South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2018-2029)
10.3 South America Short Bowel Syndrome (SBS) Drugs Market Size by Country
10.3.1 South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11.1 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2018-2029)
11.3 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Market Size by Country
11.3.1 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12.1 Short Bowel Syndrome (SBS) Drugs Market Drivers
12.2 Short Bowel Syndrome (SBS) Drugs Market Restraints
12.3 Short Bowel Syndrome (SBS) Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13.1 Raw Material of Short Bowel Syndrome (SBS) Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Short Bowel Syndrome (SBS) Drugs
13.3 Short Bowel Syndrome (SBS) Drugs Production Process
13.4 Short Bowel Syndrome (SBS) Drugs Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Short Bowel Syndrome (SBS) Drugs Typical Distributors
14.3 Short Bowel Syndrome (SBS) Drugs Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Sale Channel, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Short Bowel Syndrome (SBS) Drugs Product and Services
Table 6. Merck Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Takeda Basic Information, Manufacturing Base and Competitors
Table 9. Takeda Major Business
Table 10. Takeda Short Bowel Syndrome (SBS) Drugs Product and Services
Table 11. Takeda Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Takeda Recent Developments/Updates
Table 13. Emmaus Medical Basic Information, Manufacturing Base and Competitors
Table 14. Emmaus Medical Major Business
Table 15. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product and Services
Table 16. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Emmaus Medical Recent Developments/Updates
Table 18. Ardelyx Basic Information, Manufacturing Base and Competitors
Table 19. Ardelyx Major Business
Table 20. Ardelyx Short Bowel Syndrome (SBS) Drugs Product and Services
Table 21. Ardelyx Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Ardelyx Recent Developments/Updates
Table 23. Naia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Naia Pharmaceuticals Major Business
Table 25. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Services
Table 26. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Naia Pharmaceuticals Recent Developments/Updates
Table 28. Nutrinia Basic Information, Manufacturing Base and Competitors
Table 29. Nutrinia Major Business
Table 30. Nutrinia Short Bowel Syndrome (SBS) Drugs Product and Services
Table 31. Nutrinia Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Nutrinia Recent Developments/Updates
Table 33. OxThera Basic Information, Manufacturing Base and Competitors
Table 34. OxThera Major Business
Table 35. OxThera Short Bowel Syndrome (SBS) Drugs Product and Services
Table 36. OxThera Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. OxThera Recent Developments/Updates
Table 38. Sancilio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Sancilio Pharmaceuticals Major Business
Table 40. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Services
Table 41. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sancilio Pharmaceuticals Recent Developments/Updates
Table 43. Zealand Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Zealand Pharma Major Business
Table 45. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product and Services
Table 46. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Zealand Pharma Recent Developments/Updates
Table 48. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Manufacturer (2018-2023) & (K Pcs)
Table 49. Global Short Bowel Syndrome (SBS) Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Short Bowel Syndrome (SBS) Drugs Average Price by Manufacturer (2018-2023) & (USD/Pcs)
Table 51. Market Position of Manufacturers in Short Bowel Syndrome (SBS) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Short Bowel Syndrome (SBS) Drugs Production Site of Key Manufacturer
Table 53. Short Bowel Syndrome (SBS) Drugs Market: Company Product Type Footprint
Table 54. Short Bowel Syndrome (SBS) Drugs Market: Company Product Application Footprint
Table 55. Short Bowel Syndrome (SBS) Drugs New Market Entrants and Barriers to Market Entry
Table 56. Short Bowel Syndrome (SBS) Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2018-2023) & (K Pcs)
Table 58. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2024-2029) & (K Pcs)
Table 59. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Short Bowel Syndrome (SBS) Drugs Average Price by Region (2018-2023) & (USD/Pcs)
Table 62. Global Short Bowel Syndrome (SBS) Drugs Average Price by Region (2024-2029) & (USD/Pcs)
Table 63. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2018-2023) & (K Pcs)
Table 64. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2024-2029) & (K Pcs)
Table 65. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Short Bowel Syndrome (SBS) Drugs Average Price by Type (2018-2023) & (USD/Pcs)
Table 68. Global Short Bowel Syndrome (SBS) Drugs Average Price by Type (2024-2029) & (USD/Pcs)
Table 69. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2018-2023) & (K Pcs)
Table 70. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2024-2029) & (K Pcs)
Table 71. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Sale Channel (2018-2023) & (USD Million)
Table 72. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Sale Channel (2024-2029) & (USD Million)
Table 73. Global Short Bowel Syndrome (SBS) Drugs Average Price by Sale Channel (2018-2023) & (USD/Pcs)
Table 74. Global Short Bowel Syndrome (SBS) Drugs Average Price by Sale Channel (2024-2029) & (USD/Pcs)
Table 75. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2018-2023) & (K Pcs)
Table 76. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2024-2029) & (K Pcs)
Table 77. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2018-2023) & (K Pcs)
Table 78. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2024-2029) & (K Pcs)
Table 79. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2018-2023) & (K Pcs)
Table 80. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2024-2029) & (K Pcs)
Table 81. North America Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2018-2023) & (K Pcs)
Table 84. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2024-2029) & (K Pcs)
Table 85. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2018-2023) & (K Pcs)
Table 86. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2024-2029) & (K Pcs)
Table 87. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2018-2023) & (K Pcs)
Table 88. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2024-2029) & (K Pcs)
Table 89. Europe Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2018-2023) & (K Pcs)
Table 92. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2024-2029) & (K Pcs)
Table 93. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2018-2023) & (K Pcs)
Table 94. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2024-2029) & (K Pcs)
Table 95. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2018-2023) & (K Pcs)
Table 96. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2024-2029) & (K Pcs)
Table 97. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2018-2023) & (K Pcs)
Table 100. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2024-2029) & (K Pcs)
Table 101. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2018-2023) & (K Pcs)
Table 102. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2024-2029) & (K Pcs)
Table 103. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2018-2023) & (K Pcs)
Table 104. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity by Country (2024-2029) & (K Pcs)
Table 105. South America Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Short Bowel Syndrome (SBS) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2018-2023) & (K Pcs)
Table 108. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Type (2024-2029) & (K Pcs)
Table 109. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2018-2023) & (K Pcs)
Table 110. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Sale Channel (2024-2029) & (K Pcs)
Table 111. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2018-2023) & (K Pcs)
Table 112. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity by Region (2024-2029) & (K Pcs)
Table 113. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Short Bowel Syndrome (SBS) Drugs Raw Material
Table 116. Key Manufacturers of Short Bowel Syndrome (SBS) Drugs Raw Materials
Table 117. Short Bowel Syndrome (SBS) Drugs Typical Distributors
Table 118. Short Bowel Syndrome (SBS) Drugs Typical Customers
List of Figures
Figure 1. Short Bowel Syndrome (SBS) Drugs Picture
Figure 2. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Type in 2022
Figure 4. Glucagon-Like Peptide-2 (GLP-2) Examples
Figure 5. Growth Hormone Examples
Figure 6. Glutamine Examples
Figure 7. Other Examples
Figure 8. Global Short Bowel Syndrome (SBS) Drugs Consumption Value by Sale Channel, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Sale Channel in 2022
Figure 10. Hospitals Examples
Figure 11. Clinics Examples
Figure 12. Retail Pharmacies Examples
Figure 13. Global Short Bowel Syndrome (SBS) Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Short Bowel Syndrome (SBS) Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity (2018-2029) & (K Pcs)
Figure 16. Global Short Bowel Syndrome (SBS) Drugs Average Price (2018-2029) & (USD/Pcs)
Figure 17. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Short Bowel Syndrome (SBS) Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Short Bowel Syndrome (SBS) Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Short Bowel Syndrome (SBS) Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Short Bowel Syndrome (SBS) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Short Bowel Syndrome (SBS) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Short Bowel Syndrome (SBS) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Short Bowel Syndrome (SBS) Drugs Average Price by Type (2018-2029) & (USD/Pcs)
Figure 32. Global Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Sale Channel (2018-2029)
Figure 33. Global Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Sale Channel (2018-2029)
Figure 34. Global Short Bowel Syndrome (SBS) Drugs Average Price by Sale Channel (2018-2029) & (USD/Pcs)
Figure 35. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Sale Channel (2018-2029)
Figure 37. North America Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Sale Channel (2018-2029)
Figure 44. Europe Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Sale Channel (2018-2029)
Figure 53. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 55. China Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Sale Channel (2018-2029)
Figure 63. South America Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Sale Channel (2018-2029)
Figure 69. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Short Bowel Syndrome (SBS) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Short Bowel Syndrome (SBS) Drugs Market Drivers
Figure 76. Short Bowel Syndrome (SBS) Drugs Market Restraints
Figure 77. Short Bowel Syndrome (SBS) Drugs Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Short Bowel Syndrome (SBS) Drugs in 2022
Figure 80. Manufacturing Process Analysis of Short Bowel Syndrome (SBS) Drugs
Figure 81. Short Bowel Syndrome (SBS) Drugs Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Merck Takeda Emmaus Medical Ardelyx Naia Pharmaceuticals Nutrinia OxThera Sancilio Pharmaceuticals Zealand Pharma
02 Jan 2024
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
